EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Refractory Hyperglycemia in Metastatic Adenocarcinoma: A Case of Suspected Paraneoplastic Hyperglucagonemia

Kenan Kassas, Sira Jaffri, Shyam Govani, Kirshima Kumari iD, Nena Kumari, Amarsimha Yerrajonna

Journal of Brown Hospital Medicine · 02.10.2026 · 5 (4)

DOI: 10.56305/001c.168757 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Brown Hospital Medicine, online erschienen am 02.10.2026. Verfasst von Kenan Kassas und 5 weiteren Autor:innen. Beteiligte Einrichtung: St. George University School of Medicine, Grenada. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paraneoplastic syndromes are uncommon manifestations of malignancy that can produce significant metabolic derangements. Paraneoplastic hyperglucagonemia due to non-pancreatic malignancy is particularly rare and may present with refractory hyperglycemia. An 84-year-old female admitted following a fall from standing height was found to have a pathological fracture of cervical spine. Imaging demonstrated a destructive mass involving C5 vertebral body with widespread metastatic disease involving the lungs and liver. Biopsy of the cervical lesion revealed metastatic adenocarcinoma of suspected pancreaticobiliary, upper gastrointestinal, or pulmonary origin. Throughout her hospital course, the patient developed persistent hyperglycemia despite escalating insulin therapy and required intensive insulin management. Further evaluation demonstrated markedly elevated serum glucagon levels of 1,116 pg./mL, while adrenocorticotropic hormone (ACTH) levels remained within normal range. Following surgical debulking of the cervical lesion, the patient’s insulin requirements substantially decreased, with subsequent improvement in glycemic control. The combination of refractory hyperglycemia, markedly elevated glucagon levels, widespread metastatic disease, and decreased insulin requirements following tumor debulking raised suspicion for a paraneoplastic endocrine process involving glucagon excess. However, tumor immunohistochemical staining for glucagon was not performed; serial glucagon measurements were unavailable, and other uncommon causes of insulin resistance, including anti-insulin receptor antibodies, were not evaluated. Therefore, ectopic glucagon secretion could not be definitively established. This case highlights the importance of considering paraneoplastic endocrine syndromes in patients with malignancy and otherwise unexplained worsening hyperglycemia despite insulin therapy.

Schlagwörter

Stichwörter der Autor:innen

AdenocarcinomaEndocrine oncologyGlucagonoma syndromeHyperglucagonemiaParaneoplastic syndrome

Autor:innen und Institutionen

  • St. George University School of Medicine, Grenada.
  • Department of Internal medicine Mercy St. Vincent Medical Center.
  • Isra University, Pakistan.
  • Department of Internal Medicine Mercy Health St. Vincent medical center.

ORCID-Profile: Kirshima Kumari

Zitieren

APA

Kassas, K., Jaffri, S., Govani, S., Kumari, K., Kumari, N., & Yerrajonna, A. (2026). Refractory Hyperglycemia in Metastatic Adenocarcinoma: A Case of Suspected Paraneoplastic Hyperglucagonemia. Journal of Brown Hospital Medicine, 5(4). https://doi.org/10.56305/001c.168757

Vancouver

Kassas K, Jaffri S, Govani S, Kumari K, Kumari N, Yerrajonna A. Refractory Hyperglycemia in Metastatic Adenocarcinoma: A Case of Suspected Paraneoplastic Hyperglucagonemia. Journal of Brown Hospital Medicine. 2026;5(4). doi:10.56305/001c.168757

BibTeX
@article{Kassas2026,
  author = {Kassas, Kenan and Jaffri, Sira and Govani, Shyam and Kumari, Kirshima and Kumari, Nena and Yerrajonna, Amarsimha},
  title = {Refractory Hyperglycemia in Metastatic Adenocarcinoma: A Case of Suspected Paraneoplastic Hyperglucagonemia},
  journal = {Journal of Brown Hospital Medicine},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.56305/001c.168757}
}
Kostenlos starten →